Product Information

GABAPENTIN ER 600 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.9984 per EA under NDC 68382060716. Its NADAC has been published 115 times since Apr 17, 2024.

The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABAPENTIN ER 600 MG TABLET

gabapentin
$0.9984per EA
High Outlier

Strength

600 mg/1

NDC

68382060716

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA203934

On Market Since

1/25/2024

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN ER 600 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 79.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9984 per EA
All-time high$4.9615 (Jun 12, 2024)
All-time low$0.9984 (Jun 17, 2026)
52-week high$1.8879
52-week low$0.9984
Median price$1.6959
Average price$2.1533
Largest weekly change-26.1% (Oct 23, 2024)
Weeks tracked115
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

-11.0%

3M

-21.8%

6M

-34.4%

1Y

-33.9%

3Y

N/A

5Y

N/A

All

-79.9%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GABAPENTIN ER 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN ER 600 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.9984 per EA (NDC 68382060716), effective Jun 24, 2026.

How has the price of GABAPENTIN ER 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN ER 600 MG TABLET has declined 79.9%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for GABAPENTIN ER 600 MG TABLET?

Since Apr 17, 2024, the NADAC for GABAPENTIN ER 600 MG TABLET has ranged from a low of $0.9984 (Jun 17, 2026) to a high of $4.9615 (Jun 12, 2024), with a median of $1.6959 per EA.

Are there cheaper alternatives to GABAPENTIN ER 600 MG TABLET?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 600 MG TABLET, is $0.0668 per EA — about 93% below GABAPENTIN ER 600 MG TABLET.

Who manufactures GABAPENTIN ER 600 MG TABLET?

GABAPENTIN ER 600 MG TABLET (NDC 68382060716) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.